Funds under The Blackstone Group are buying the private specialty firm Ayumi Pharmaceutical, in a signal that the US private equity giant sees attractive returns down the road from what is its first controlling private investment in Japan.
Blackstone Bets On Pharma In First Japan Buy, But Why?
Major private equity group Blackstone buys into pharma for its first acquisition in Japan, but amid challenges in the sector, the attractions take some unraveling.
